This inventor holds 11 USPTO granted patents. Top assignees: Kirin Beer Kabushiki Kaisha, Nps Pharmaceuticals, Inc., Kirin Brewery Company, Limited. Active years: 1995-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gunma, JP (1995 - 2006)
- Takasaki, JP (1995 - 2009)
Company Filing History:
7 out of 215 
2 out of 93 
1 out of 42 Years Active: 1995-2009
Title: The Innovations of Teruyuki Sakai
Introduction
Teruyuki Sakai, an inventive mind hailing from Gunma, Japan, has made significant strides in the field of biotechnology and pharmaceuticals. With a portfolio of 11 patents, his work primarily focuses on the development of novel compounds aimed at inhibiting cancer growth.
Latest Patents
Sakai's recent contributions include groundbreaking patents for quinoline and quinazoline derivatives that target the autophosphorylation of fibroblast growth factor receptors. The objective of these inventions is to provide compounds with inhibitory activity against FGF receptors, ultimately suppressing the growth of cancer cells when administered orally or intravenously. The chemical formulations of these compounds are carefully designed, where elements like X, Z, and Q can represent various molecular configurations to enhance their pharmacological effects.
Another noteworthy patent involves quinoline derivatives and quinazoline derivatives featuring an azolyl group. These compounds have demonstrated potent antitumor activity, further establishing Sakai’s commitment to cancer research and therapeutic development.
Career Highlights
Throughout his career, Teruyuki Sakai has worked with reputable organizations such as Kirin Beer Kabushiki Kaisha and NPS Pharmaceuticals, Inc. His experience in these companies has allowed him to hone his expertise in pharmaceuticals, paving the way for his innovative inventions.
Collaborations
Sakai has collaborated with notable professionals in his field, including Rika Nagao and Yasunari Fujiwara. These partnerships have significantly contributed to the success of his research and the advancement of his inventions in cancer treatment.
Conclusion
Teruyuki Sakai stands out as a prominent inventor in the pharmaceutical industry, with a dedication to developing compounds that can potentially change the landscape of cancer therapy. His innovations reflect a blend of creativity and scientific rigor, affirming his place in the realm of modern biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile